CD8A and non-small cell lung carcinoma: The peripheral blood CD8 + T cells of patients in the effective group decreased mildly, which was the same as the changes observed in oral cancer and non-small cell lung cancer treated with PD-1 inhibitors in previous studies [24, 25].